ISMAEL MERCADO: Open Payments
NPI 1376521997 · BAYAMON, PR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 10 payments from 7 companies in 2025. Trend: 2023 $713 · 2024 $768 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $163 |
| Lilly USA, LLC | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Amneal Pharmaceuticals LLC | 1 | $114 |
| Becton, Dickinson and Company | 1 | $74 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
Products named: ZEPBOUND, AIRSUPRA, CREXONT, CAPVAXIVE, RotarexS 6 F x 135 cm, GARDASIL 9, Tlando, PAXLOVID.
Industry payments across PR — which companies pay providers there.
